Skip to content

FIBRILIN vial 3 ml

by Laboratorios Farmacéuticos Rovi, S.A.

Ref FIBRILIN vial 3 ml

Active European Union

CE MDR

Valid until

22 Feb 2031

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier CENTRO NACIONAL DE CERTIFICACION DE PRODUCTOS SANITARIOS

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 24 Oct 2026. What this means

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number843658324FIBRILIN7Q Basic UDI-DI 08436583241240UDI-DIDate21 May 2026RegisteredStatusActive

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • 2026 DR 0079 Active

    Technical documentation EU MDR

    Certifier
    CENTRO NACIONAL DE CERTIFICACION DE PRODUCTOS SANITARIOS 0318
    Issued
    23 Feb 2026
    Expires
    22 Feb 2031

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Model / Reference
FIBRILIN vial 3 ml
Primary DI / UDI-DI
08436583241240
Basic UDI-DI
843658324FIBRILIN7Q
EMDN Code
V9099 Various devices not included in other classes - other
Device Class
Class III
EU market of registration
Spain

Manufacturer details

EUDAMED SRN
ES-MF-000014579

Related devices

Category: Device sterilization/disinfection container, reusable

Other devices from Laboratorios Farmacéuticos Rovi, S.A.

Properties

  • Sterile
  • Animal Tissues
  • Incorporates Medicinal Product

Other properties (10)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No